Abstract:The polyketide specialized metabolites of bacteria are attractive targets for generating analogues, with the goal of improving their pharmaceutical properties. Here, we aimed to produce C-26 derivatives of the giant anti-cancer stambomycin macrolides using a mutasynthesis approach, as this position has been shown previously to directly impact bioactivity. For this, we leveraged the intrinsically broad specificity of the acyl transferase domain (AT12) of the modular polyketide synthase (PKS), which is responsible for the alkyl branching functionality at this position. Feeding of a panel of synthetic and commercially available dicarboxylic acid "mutasynthons" to an engineered strain of Streptomyces ambofaciens (Sa) deficient in synthesis of the native alpha-carboxyacyl-CoA extender units, resulted in six new series of stambomycin derivatives as judged by LC-HRMS and NMR. Notably, the highest product yields were observed for substrates which were only poorly accepted when AT12 was transplanted into a different PKS module, suggesting a critical role for domain context in the overall functioning of PKS proteins. We also demonstrate the superiority of this mutasynthesis approach - both in terms of absolute titers and yields relative to the parental compounds - in comparison to the alternative precursor-directed strategy in which monoacid building blocks are supplied to the wild type strain. We further identify a malonyl-CoA synthetase, MatB_Sa, with specificity distinct from previously identified promiscuous enzymes, making it a useful addition to a mutasynthesis toolbox for generating atypical, CoA activated extender units. Finally, we show that two of the obtained (deoxy)-butyl-stambomycins exhibit antibacterial and antiproliferative activities similar to the parental stambomycins, while an unexpected butyl-demethyl congener is less potent. Overall, this works confirms the interest of biosynthetic pathways which combine a dedicated route to extender unit synthesis and a broad specificity AT domain for producing bioactive derivatives of fully-elaborated complex polyketides.

Insights into bacterial 6-methylsalicylic acid synthase and its engineering to orsellinic acid synthase for spirotetronate generation

Molecular engineering of thiostrepton via single “base”-based mutagenesis to generate side ring-derived variants

Improved Expression of His(6)-Tagged Strictosidine Synthase Cdna for Chemo-Enzymatic Alkaloid Diversification

Using Strictosidine Synthase to Prepare Novel Alkaloids.

Co-expression of a SARP Family Activator ChlF2 and a Type II Thioesterase ChlK Led to High Production of Chlorothricin in Streptomyces antibioticus DSM 40725

Genetic Characterization of the Chlorothricin Gene Cluster As a Model for Spirotetronate Antibiotic Biosynthesis

Engineering of Cyclohexanone Monooxygenase for the Enantioselective Synthesis of (S)-Omeprazole

Recreating the natural evolutionary trend in key microdomains provides an effective strategy for engineering of a thermomicrobial <i>N</i>-demethylase

Protein engineering of thioether monooxygenase to improve its thermostability for enzymatic synthesis of chiral sulfoxide

Chemoenzymatic Synthesis and Biological Evaluation for Bioactive Molecules Derived from Bacterial Benzoyl Coenzyme A Ligase and Plant Type III Polyketide Synthase

Dissection of Two Acyl‐Transfer Reactions Centered on Acyl‐S‐Carrier Protein Intermediates for Incorporating 5‐chloro‐6‐methyl‐o‐methylsalicyclic Acid into Chlorothricin

Cloning and Characterization of the Tetrocarcin A Gene Cluster from Micromonospora Chalcea NRRL 11289 Reveals a Highly Conserved Strategy for Tetronate Biosynthesis in Spirotetronate Antibiotics

Structural Insights into the Substrate Specificity of Acyltransferases from Salinomycin Polyketide Synthase

Rational and Semirational Approaches for Engineering Salicylate Production in Escherichia coli

Cloning and Characterization of a Bacterial Iterative Type I Polyketide Synthase Gene Encoding the 6-Methylsalicyclic Acid Synthase

Insights into 6-Methylsalicylic Acid Bio-assembly by Using Chemical Probes

Exploiting the inherent promiscuity of the acyl transferase of the stambomycin polyketide synthase for the mutasynthesis of analogues

Biosynthetically Guided Structure-Activity Relationship Studies of Merochlorin A, an Antibiotic Marine Natural Product.

Structure-Based Design and Development of Phosphine Oxides as a Novel Chemotype for Antibiotics that Dysregulate Bacterial ClpP Proteases

Combinatorial Effect of ARTP Mutagenesis and Ribosome Engineering on an Industrial Strain of Streptomyces Albus S12 for Enhanced Biosynthesis of Salinomycin.

Protein engineering of carbonyl reductase for asymmetric synthesis of ticagrelor precursor (1S)-2-chloro-1-(3,4-difluorophenyl)ethanol